Fig. 1From: Pyrroloquinoline quinone drives ATP synthesis in vitro and in vivo and provides retinal ganglion cell neuroprotectionEffects of PQQ administration on RGC survival in ex vivo and in vivo models of RGC stress. A Representative images of retinas cultured ex vivo, immunolabeled for RNA-binding protein with multiple splicing (RBPMS, red) and counterstained with DAPI (blue). Retinal explants were cultured in either basic or supplemented media with either 50 or 100 μM PQQ for 3 days ex vivo (DEV). Control retinas (0 DEV) were directly fixed and processed after the dissection. B Quantification of RBPMS positive cell density per 0.01 mm2. n = 5 (0 DEV), 9 (3 DEV), 4 (3 DEV + 50 μM PQQ), 6 (3 DEV + 100 μM PQQ) retinas. C Representative images of retinas from mice injected with either DMSO or rotenone and treated with either vehicle or 20 mg/kg PQQ. Flat mount retinas were immunolabeled for RBPMS (red) and counterstained with DAPI (blue). D Quantification of RBPMS positive cell density per 0.01 mm2. n = 9 DMSO, 9 DMSO + PQQ, 10 rotenone and 9 rotenone + PQQ retinas. Scale bar = 20 μm. *p < 0.05, **p < 0.01 and ***p < 0.001 versus 0 DEV (explants) or DMSO (rotenone model); #p < 0.01 and ##p < 0.001 versus 3 DEV (explants) or rotenone (rotenone model)Back to article page